版本:
中国

BRIEF-Paratek pharmaceuticals Q1 loss per share $1.14

May 4 Paratek Pharmaceuticals Inc

* Paratek pharmaceuticals, inc. Reports first quarter 2017 financial results and provides clinical update

* Q1 loss per share $1.14

* Q1 earnings per share view $-1.20 -- Thomson Reuters I/B/E/S

* As of march 31, 2017, paratek had cash, cash equivalents, and marketable securities of $139.6 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐